CHEN JIN-LONG 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Mar 4, 2022
Insider Transaction Report
Form 4
CHEN JIN-LONG
DirectorChief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-03+175,000→ 175,000 totalExercise: $15.20Exp: 2032-03-02→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period commencing January 1, 2022, with 1/48th of the shares vesting on a monthly basis.